Comments

Aura Biosciences Stock Price, Quotes and Forecasts

Q: What sector and industry does Aura Biosciences (AURA) operate in?

Aura Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

AURANASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$6.34

0.406.73%

At close: -

$6.45

0.111.74%

After Hours: Mar 28, 4:38 PM EDT

Q4 2024 Earnings were released on Mon Mar 24th, after the market close

Aura Biosciences (AURA) Forecast

News Earnings Aura Biosciences (AURA) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Aura Biosciences Stock Price, Quotes and Forecasts | NASDAQ:AURA | Benzinga

Explore Aura Biosciences stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for AURA.

Open	$5.96
Close	$6.34
Volume / Avg.	3.12M / 169.77K
Day Range	$5.85 - $6.36
52 Wk Range	5.77 - 12.38
Market Cap	$323.95M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	33
Short Interest	3.21%
Days to Cover	7.37

Recent News

US Stocks Likely To Open Mixed: 'Expect Volatility. Buckle Up,' Says Expert

U.S. stock futures were swinging between gains and losses on Thursday after snapping a three-day winning streak on Wednesday. Futures of major benchmark indices were mixed in premarket trading. Aiming to boost U.S. manufacturing and reduce reliance on global suppliers, new auto tariffs were introduced on Wednesday, which will go into effect from April 3.

Rishabh Mishra

Why Greenland Technologies Shares Are Trading Higher By Around 89%; Here Are 20 Stocks Moving Premarket

Avi Kapoor

Why Check-Cap Shares Are Trading Higher By Over 52%; Here Are 20 Stocks Moving Premarket

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Oct 24

Nov 24

Mar

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.5

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$5.96
Close	$6.34
Volume / Avg.	3.12M / 169.77K
Day Range	$5.85 - $6.36
52 Wk Range	5.77 - 12.38
Market Cap	$323.95M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	33
Short Interest	3.21%
Days to Cover	7.37

About Aura Biosciences Inc

Sector

Health Care

Industry

Biotechnology

Aura Biosciences Inc is a clinical-stage biotechnology company developing precision immunotherapies ...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Aura Biosciences (AURA) stock?

You can purchase shares of Aura Biosciences (NASDAQ:AURA) through any online brokerage.

View our list of the best stock brokerages

Who are Aura Biosciences (AURA) competitors?

Other companies in Aura Biosciences’s space includes: Humacyte (NASDAQ:HUMA), Monopar Therapeutics (NASDAQ:MNPR), aTyr Pharma (NASDAQ:ATYR), Monte Rosa Therapeutics (NASDAQ:GLUE) and Olema Pharmaceuticals (NASDAQ:OLMA).

What is the forecast, or price target, for Aura Biosciences (AURA) stock?

Aura Biosciences has a consensus price target of $22.80.

What is the current price for Aura Biosciences (AURA)?

The stock price for Aura Biosciences (NASDAQ: AURA) is $6.45 last updated March 28, 2025 at 4:38 PM EDT.

Does Aura Biosciences (AURA) pay a dividend?

There are no upcoming dividends for Aura Biosciences.

When is Aura Biosciences (NASDAQ:AURA) reporting earnings?

Aura Biosciences’s Q1 earnings are confirmed for Thursday, May 8, 2025.

Is Aura Biosciences (AURA) going to split?

There is no upcoming split for Aura Biosciences.

What sector and industry does Aura Biosciences (AURA) operate in?

Aura Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.